Neurotuberculosis: A Clinical Review

Abstract

In September 2018, the United Nations General Assembly held the first ever meeting to discuss the global epidemic of tuberculosis (TB) and adopted a political declaration titled “United to end tuberculosis: an urgent global response to a global epidemic.” The timing of the meeting was prescient but overdue since Mycobacterium tuberculosis surpassed the human immunodeficiency virus as the world's leading infectious killer in 2014. Infection of the central nervous system by Mycobacterium tuberculosis, herein referred to as neurotuberculosis, is the most feared and dangerous form of tuberculosis, requiring a high level of suspicion and clinical experience for prompt diagnosis and treatment. Neurologists, infectious disease specialists, orthopedic surgeons, neurosurgeons, and hospitalists in all countries need to recognize the spectrum of neurotuberculosis and be able to integrate clinical information, laboratory data, and radiological findings to make a diagnosis with or without microbiological confirmation.

Keywords

tuberculosis - meningitis - cerebrospinal fluid - HIV - Xpert

• References

• 1 United Nations General Assembly. 73/3. Political declaration of the high-level meeting of the General Assembly on the fight against tuberculosis. Available at: http://www.un.org/en/ga/search/view_doc.asp?symbol=A/RES/73/3 . Accessed March 26, 2019
• 2 Wiens KE, Woyczynski LP, Ledesma JR. , et al. Global variation in bacterial strains that cause tuberculosis disease: a systematic review and meta-analysis. BMC Med 2018; 16 (01) 196
• 3 WHO. Global Tuberculosis Report 2018. Available at: http://www.who.int/tb/publications/global_report/en/ . Accessed March 26, 2019
• 4 García-Basteiro AL, Brew J, Williams B, Borgdorff M, Cobelens F. What is the true tuberculosis mortality burden? Differences in estimates by the World Health Organization and the Global Burden of Disease study. Int J Epidemiol 2018; 47 (05) 1549-1560
• 5 Vachon J, Gallant V, Siu W. Tuberculosis 2016–Supplementary Tables. Web exclusive. CCDR-44-3/4. Available at: https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2018-44/issue-3-4-march-1-2018/article-2-tuberculosis-2016-supplementary-tables.html . Accessed March 26, 2019
• 6 Souza CH, Yamane A, Pandini JC. , et al. Incidence of tuberculous meningitis in the State of Santa Catarina, Brazil. Rev Soc Bras Med Trop 2014; 47 (04) 483-489
• 7 Public Health England. (2018) Tuberculosis in England: 2018. Public Health England, London. Available at: https://www.gov.uk/government/publications/tuberculosis-in-england-annual-report . Accessed April 12, 2019
• 8 Chaidir L, Ganiem AR, Vander Zanden A. , et al. Comparison of real time IS6110-PCR, microscopy, and culture for diagnosis of tuberculous meningitis in a cohort of adult patients in Indonesia. PLoS One 2012; 7 (12) e52001
• 9 Heemskerk AD, Nguyen MTH, Dang HTM. , et al. Clinical outcomes of patients with drug-resistant tuberculous meningitis treated with an intensified antituberculosis regimen. Clin Infect Dis 2017; 65 (01) 20-28
• 10 Cresswell FV, Bangdiwala AS, Meya DB. , et al. Absence of cerebrospinal fluid pleocytosis in tuberculous meningitis is a common occurrence in HIV co-infection and a predictor of poor outcomes. Int J Infect Dis 2018; 68: 77-78
• 11 Marais S, Thwaites G, Schoeman JF. , et al. Tuberculous meningitis: a uniform case definition for use in clinical research. Lancet Infect Dis 2010; 10 (11) 803-812
• 12 Heemskerk AD, Donovan J, Thu DDA. , et al. Improving the microbiological diagnosis of tuberculous meningitis: a prospective, international, multicentre comparison of conventional and modified Ziehl-Neelsen stain, GeneXpert, and culture of cerebrospinal fluid. J Infect 2018; 77 (06) 509-515
• 13 Thwaites GE, van Toorn R, Schoeman J. Tuberculous meningitis: more questions, still too few answers. Lancet Neurol 2013; 12 (10) 999-1010
• 14 Török ME. Tuberculous meningitis: advances in diagnosis and treatment. Br Med Bull 2015; 113 (01) 117-131
• 15 Kashyap RS, Kainthla RP, Mudaliar AV, Purohit HJ, Taori GM, Daginawala HF. Cerebrospinal fluid adenosine deaminase activity: a complimentary tool in the early diagnosis of tuberculous meningitis. Cerebrospinal Fluid Res 2006; 3: 5
• 16 Albert H, Nathavitharana RR, Isaacs C, Pai M, Denkinger CM, Boehme CC. Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better?. Eur Respir J 2016; 48 (02) 516-525
• 17 Senbayrak S, Ozkutuk N, Erdem H. , et al. Antituberculosis drug resistance patterns in adults with tuberculous meningitis: results of haydarpasa-iv study. Ann Clin Microbiol Antimicrob 2015; 14: 47
• 18 Patel VB, Padayatchi N, Bhigjee AI. , et al. Multidrug-resistant tuberculous meningitis in KwaZulu-Natal, South Africa. Clin Infect Dis 2004; 38 (06) 851-856
• 19 Kohli M, Schiller I, Dendukuri N. , et al. Xpert^® MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance. Cochrane Database Syst Rev 2018; 8 (08) CD012768
• 20 Chakravorty S, Simmons AM, Rowneki M. , et al. The new Xpert MTB/RIF Ultra: improving detection of Mycobacterium tuberculosis and resistance to rifampin in an assay suitable for point-of-care testing. MBio 2017; 8 (04) e00812-e00817
• 21 WHO. WHO Meeting Report of a Technical Expert Consultation: non-inferiority analysis of Xpert MTB/RIF Ultra compared to Xpert MTB/RIF. Available at: http://www.who.int/tb/publications/2017/XpertUltra/en/ . Accessed March 26, 2019
• 22 Bahr NC, Nuwagira E, Evans EE. , et al; ASTRO-CM Trial Team Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort study. Lancet Infect Dis 2018; 18 (01) 68-75
• 23 Chin JH. Xpert MTB/RIF Ultra: the long-awaited game changer for tuberculous meningitis?. Eur Respir J 2017; 50 (04) 1701201
• 24 Cohen DB, Zijlstra EE, Mukaka M. , et al. Diagnosis of cryptococcal and tuberculous meningitis in a resource-limited African setting. Trop Med Int Health 2010; 15 (08) 910-917
• 25 Ellis J, Cresswell FV, Rhein J, Ssebambulidde K, Boulware DR. Cryptococcal meningitis and tuberculous meningitis co-infection in HIV-infected Ugandan adults. Open Forum Infect Dis 2018; 5 (08) ofy193
• 26 Antinori S, Corbellino M, Meroni L. , et al. Aspergillus meningitis: a rare clinical manifestation of central nervous system aspergillosis. Case report and review of 92 cases. J Infect 2013; 66 (03) 218-238
• 27 Modi M, Sharma K, Prabhakar S. , et al. Clinical and radiological predictors of outcome in tubercular meningitis: a prospective study of 209 patients. Clin Neurol Neurosurg 2017; 161: 29-34
• 28 Chiang SS, Khan FA, Milstein MB. , et al. Treatment outcomes of childhood tuberculous meningitis: a systematic review and meta-analysis. Lancet Infect Dis 2014; 14 (10) 947-957
• 29 Rizvi I, Garg RK, Malhotra HS. , et al. Ventriculo-peritoneal shunt surgery for tuberculous meningitis: a systematic review. J Neurol Sci 2017; 375: 255-263
• 30 Chatterjee D, Radotra BD, Vasishta RK, Sharma K. Vascular complications of tuberculous meningitis: an autopsy study. Neurol India 2015; 63 (06) 926-932
• 31 Kim TK, Chang KH, Kim CJ, Goo JM, Kook MC, Han MH. Intracranial tuberculoma: comparison of MR with pathologic findings. AJNR Am J Neuroradiol 1995; 16 (09) 1903-1908
• 32 Algahtani HA, Aldarmahi AA, Algahtani AY, Al-Rabia MW, Samkari AM. Tumour-like presentation of central nervous system tuberculosis: a retrospective study in Kingdom of Saudi Arabia. J Taibah Univ Med Sci 2014; 9: 143-150
• 33 Brouwer MC, Tunkel AR, McKhann II GM, van de Beek D. Brain abscess. N Engl J Med 2014; 371 (05) 447-456
• 34 Garg RK, Somvanshi DS. Spinal tuberculosis: a review. J Spinal Cord Med 2011; 34 (05) 440-454
• 35 WHO. Treatment of tuberculosis: guidelines – 4th ed. 2010. Available at: http://www.who.int/tb/publications/2010/9789241547833/en/ . Accessed March 26, 2019
• 36 WHO. Guidance for national tuberculosis programmes on the management of tuberculosis in children – 2nd ed. 2014. Available at: http://www.who.int/tb/publications/childtb_guidelines/en/ . Accessed March 26, 2019
• 37 WHO. Guidelines for treatment of drug-susceptible tuberculosis and patient care. 2017 Update. Available at: http://www.who.int/tb/publications/2017/dstb_guidance_2017/en/ . Accessed March 26, 2019
• 38 WHO. Index-TB Guidelines. Guidelines on extra-pulmonary tuberculosis for India. Available at: https://tbcindia.gov.in/showfile.php?lid=3245 . Accessed March 26, 2019
• 39 Department of Health. Republic of South Africa. National Tuberculosis Management Guidelines. 2014. Available at: https://www.health-e.org.za/wp-content/uploads/2014/06/NTCP_Adult_TB-Guidelines-27.5.2014.pdf . Accessed March 26, 2019
• 40 Prasad K, Singh MB, Ryan H. Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev 2016; 4: CD002244
• 41 Török ME, Yen NT, Chau TT. , et al. Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)--associated tuberculous meningitis. Clin Infect Dis 2011; 52 (11) 1374-1383
• 42 Dheda K, Gumbo T, Maartens G. , et al. The epidemiology, pathogenesis, transmission, diagnosis, and management of mutidrug-resistant, extensively drug-resistant, and incurable tuberculosis. Lancet Respir Med 2017; 5: 291-360